Editorial by Bruce and Beverly Shriver
Letter to the Editor: Dr. CR Chandrasekar highlights the importance of sarcoma awareness and discusses strategies for improving it.
A.D. Schenone and Dr. Brian Van Tine review the literature to identify validated biomarkers of the chemotherapies that are used for sarcoma treatment.
Experimental Plan: Investigators Dutor and Blay aim to characterize the chondrosarcoma immunological niche and determine its potential role in tumor progression and response to targeted therapy.
Experimental Plan: Investigators Myklebost, Thomas, Meza-Zepeda and Wagner continue their research addressing key questions in liposarcoma.
The Liddy Shriver Sarcoma Initiative is funding a new study on chondrosarcoma.
The Liddy Shriver Sarcoma Initiative and the Wendy Walk announce an International Collaborative Grant for research on well-differentiated and dedifferentiated liposarcomas.